Record Display for the EPA National Library Catalog

RECORD NUMBER: 14 OF 144

OLS Field Name OLS Field Data
Main Title Development document for effluent guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category /
Other Authors
Author Title of a Work
Gorsuch, Anne McGill
CORP Author Environmental Protection Agency, Washington, DC. Effluent Guidelines Div.
Publisher Effluent Guidelines Division, Office of Water, U.S. Environmental Protection Agency,
Year Published 1982
Report Number EPA 440-1-82-084
Stock Number PB94-120110
OCLC Number 10806908
Subjects Pharmaceutical industry--Evaluation. ; Drug industry ; Industrial waste treatment ; Chemical effluents ; Pollution regulations ; Water pollution control ; Water pollution abatement ; Waste water ; Point sources ; Industrial plants ; Water pollution sampling ; Water pollution economics ; Economic impact ; Pretreatment ; Treatment technology ; BAT(Best available technology)
Additional Subjects Drug industry ; Industrial waste treatment ; Chemical effluents ; Pollution regulations ; Water pollution control ; Water pollution abatement ; Waste water ; Point sources ; Industrial plants ; Water pollution sampling ; Water pollution economics ; Economic impact ; Pretreatment ; Treatment technology ; BAT(Best available technology)
Internet Access
Description Access URL
http://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=000011MB.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EHAD  EPA/440-1-82-084 Region 1 Library/Boston,MA 04/09/1999
ERAD  EPA 440/1-82-084b Region 9 Library/San Francisco,CA 03/25/2016
NTIS  PB94-120110 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 01/01/1988
Collation 1 volume (various pagings) : charts ; 28 cm
Abstract
The document presents the technical data to support effluent limitations for the pharmaceutical manufacturing point source category as required by the Clean Water Act (The Act) and related settlement agreements. It also presents the technologies to achieve limitations as defined by an amended best practicable control technology currently available (BPT), best available technology economically achievable (BAT) and best conventional pollutant control technology (BCT), and standards as defined by new source performance standards (NSPS), and pretreatment standards for new and existing sources (PSNS and PSES). The pharmaceutical manufacturing point source category manufacture biological products, medicinal chemicals, botanical products and pharmaceutical products.
Notes
"November 1982." "EPA 400/1-82/084."